Pendulum Therapeutics

Pendulum Therapeutics is a biotechnology company founded in 2013 that focuses on microbiome science. The company develops innovative probiotic formulations aimed at supporting metabolic health. Led by CEO Colleen Cutcliffe, who has a Ph.D. in Biochemistry and Molecular Biology, Pendulum is dedicated to improving lives through microbiome-targeted medical probiotics. The company offers a range of products designed to enhance metabolic health and gut wellness, including Pendulum Glucose Control, the first medical probiotic clinically proven to improve A1C levels in individuals with type 2 diabetes. Other products include Akkermansia, a novel probiotic strain, Metabolic Daily for metabolism support, and Polyphenol Booster to increase antioxidants. Pendulum Therapeutics is recognized for its commitment to research and innovation, partnering with institutions like the Mayo Clinic to advance microbiome research. The company has received strategic investments to enhance its offerings and is endorsed by health professionals, making its products available through various retail channels.

Biotechnology San Francisco, United States Founded 2012 ~116 employees

Work at Pendulum Therapeutics in HR or recruiting? Claim this page

Employees
116
+2.7% in the 3 months to Sep 2026
Revenue / employee
$25.9K
Revenue ~$3M
Total funding
$121M
Last round Jun 2023
12-month attrition
20.9%
Tech: 14.4%
H1B filings, FY2025
1
Sponsors visas
Open jobs
5
Last 30 days

Headcount trend

Pendulum Therapeutics went from 118 employees in Oct 2024 to 116 in Sep 2026. Apr to Sep 2026: 10 people joined, 5 left.

Org structure

Headcount by department

Other44
Operations21
Engineering16
Marketing13
Finance9
Design5
HR3
Sales2

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering1

Funding

  • Jun 2023 · $10M · Fonterra Co-operative Group Limited
  • Apr 2021 · Series C · $54M · Meritech Capital, Seqouia Capital, True Ventures
  • May 2019 · Series B · $35M · Seqouia Capital, True Ventures, Khosla Ventures
  • Jun 2017 · Series A · $18.5M · True Ventures, Khosla Ventures
  • Dec 2014 · Seed · $3.5M · True Ventures, Felicis Ventures

Peer reviews

Worked with someone at Pendulum Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Hiring now

Similar companies

Pendulum Therapeutics FAQ

How many employees does Pendulum Therapeutics have?

Pendulum Therapeutics has about 116 employees, up 2.7% over the 3 months to Sep 2026.

Does Pendulum Therapeutics sponsor H1B visas?

Yes. Pendulum Therapeutics filed 1 H1B (LCA) application in FY2025, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

What is Pendulum Therapeutics's revenue per employee?

Pendulum Therapeutics makes about $26K in revenue per employee, based on $3M annual revenue and 116 employees.

How much funding has Pendulum Therapeutics raised?

Pendulum Therapeutics has raised $121M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.